Latest news with #GoodLaboratoryPractices
Fashion Value Chain
2 days ago
- Business
- Fashion Value Chain
Pharmacy Council of India Gives Nod to Chandigarh University, Uttar Pradesh to Launch Courses at School of Pharmacy
Chandigarh University, Uttar Pradesh, continues to break new ground in AI-augmented multidisciplinary education with a major milestone-its School of Pharmacy has received formal approval from the Pharmacy Council of India (PCI) for its Bachelor of Pharmacy (B. Pharma) programme. This development marks a significant step in establishing Uttar Pradesh as a forward-looking destination for pharmacy education. Chandigarh University Uttar Pradesh Officials After Receiving the Approval Letter from Pharmacy Council of India for Kick Starting Programs in Pharmacy at CU UP Campus The School of Pharmacy at CU Uttar Pradesh has been conceptualized with a future-ready educational model aligned with industry demands and driven by cutting-edge technology. The curriculum is designed to balance theoretical foundations with hands-on training, ensuring that students graduate as competent and industry-ready healthcare professionals. The Pharmacy Council of India has granted formal approval to Chandigarh University, Lucknow Campus to begin offering 60 seats in the Pharmacy course from the academic session 2025. State-of-the-Art Infrastructure for Research-Driven Learning The School of Pharmacy offers an infrastructure tailored for advanced research. Students actively participate in projects related to pharmacokinetics, clinical pharmacy, medicinal chemistry, and toxicology. The curriculum has been crafted in collaboration with international industry experts and academicians, enabling students to grasp both traditional and emerging subjects with clarity while sharpening their skills in line with global standards. The availability of AI-powered tools and modern laboratories encourages experiential learning. Students also engage in internships, research assignments, and community-driven projects, making education at CU not only theoretical but deeply practical and immersive. A Booming Sector with Expanding Opportunities With the global pharmaceutical industry projected to grow at an estimated rate of 4.7% from 2024 to 2029-reaching a market size of approximately USD 1,454 billion-career prospects in pharmacy remain robust. Recognizing this trend, Chandigarh University has developed an ecosystem equipped with high-tech labs, experienced industry professionals, and collaborative learning environments to prepare a skilled and adaptable workforce. Industry-Collaborated Education for Future-Ready Professionals Students at the School of Pharmacy can pursue careers in diverse fields such as Clinical Research, Intellectual Property Management, Regulatory Affairs, Quality Control, and Medical Writing. The university also imparts regulatory training in Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP), ensuring graduates are prepared to work in highly regulated environments. Chandigarh University, Uttar Pradesh, stands as a model of integrated education where learning, technology, and industry interface seamlessly. Students not only receive rigorous academic instruction but also benefit from industry training, internships, and research exposure, preparing them for a balanced and successful career. The universitys AI-supported, modern campus in Unnao-backed by industry-aligned curriculum, advanced labs, and seasoned faculty-provides a solid academic foundation. Strategic partnerships with leading companies and government bodies further enhance student opportunities by offering essential skill training and diverse career pathways. Academic Leadership at the Helm The school is led by Prof. (Dr.) Amit Verma. Prof. Verma is accompanied by rich international, industry, and academic experience. Having more than 20 years of pharmaceutical education, research, and industrial experience, Prof. Verma has made notable contributions towards international collaborations, drug development plans, regulatory documentation, and innovation in pharmaceutical sciences. He has collaborated with Indias and the worlds premier institutions and pharmaceutical industries, providing his services in drug discovery, formulation science, regulatory affairs, clinical research and academic leadership. His passion for pharmacy education is evident in his strong desire for interactive learning, digital integration, research mentorship, and international academic collaborations. Being the Indias first AI-enabled campus Chandigarh University Uttar Pradesh is committed to revolutionize education through modern technology. This smart campus offers AI-powered learning platforms, real-time simulation, virtual labs, that foster an environment of incubation, innovation and critical thinking. The university believe in quality professional education where the eminent faculty on roll are equipped with advanced pedagogy to produce pharmacy professionals to not only adept in their field but also competent in leveraging technology to enhance patient care and drug development. This initiative and commitment ensure our dedication to shape future-ready pharmacy leaders to meet healthcare industry requirement. Backed with the legacy of Chandigarh University Mohali, students will get an opportunity for the international exposure through the collaborations with over 150 foreign universities, enriching their academic and cultural perspectives. Chandigarh University Uttar Pradesh is committed to nurturing competent and compassionate pharmacy professionals who can contribute meaningfully to the global healthcare ecosystem'. About Chandigarh University Uttar Pradesh (Lucknow) Envisioned to foster a culture of sustainability and empower future global leaders, Chandigarh University, Uttar Pradesh, immerses 21st-century learners in a personalised and experiential learning experience, integrating an AI-powered academic model and a multidimensional, futuristic perspective on education. Our Uttar Pradesh campus carries forward the venerable legacy of more than a decade of Chandigarh University, Punjab, which has established itself as Indias No. 1 Private University and a torchbearer of groundbreaking pedagogy and research-driven innovation. The AI-augmented new campus offers a broad spectrum of industry-driven futuristic academic programs encompassing data-driven insights, virtual reality experiences, real-world simulations, corporate mentorship, international perspective, interdisciplinary research, cultivation of entrepreneurial spirit, and professional competencies. Website:
Yahoo
7 days ago
- Business
- Yahoo
Charles River Laboratories International, Inc. (CRL): A Bull Case Theory
We came across a bullish thesis on Charles River Laboratories International, Inc. (CRL) on scuttleblurb's Substack. In this article, we will summarize the bulls' thesis on CRL. Charles River Laboratories International, Inc. (CRL)'s share was trading at $136.25 as of 28th May. CRL's trailing and forward P/E were 25.07 and 14.41 respectively according to Yahoo Finance. A technician in a lab inspecting an ELISA test kit for use in biopharmaceutical diagnostics. Life sciences companies produce tangible tools like assays, bioreactors, and chromatography columns used across three key drug development phases: preclinical, clinical, and manufacturing. The preclinical phase, often split into discovery and regulatory safety testing, involves identifying and optimizing drug candidates through high-throughput screening and ADME-Tox tests, assessing absorption, distribution, metabolism, excretion, and toxicity. Charles River plays a significant role here by supplying cells and animals for testing, running screenings, and conducting ADME evaluations, although early discovery is mostly handled in-house due to its exploratory nature. As drug candidates progress, testing becomes more regulated, and outsourcing rises, particularly for Safety Assessment, which focuses on toxicity testing using larger mammals under strict Good Laboratory Practices (GLP). Charles River excels at these structured studies, which form about 60% of tox testing and require rigorous documentation and quality assurance. After successful safety testing, drugs enter clinical trials where clinical CROs lead, but Charles River remains involved through its Microbial Solutions and Biologics Testing divisions, ensuring drugs are free from microbial contamination and validating biologics' purity, potency, and safety. Despite initial attempts to enter drug manufacturing (CDMO) through acquisitions, Charles River exited a crowded small molecule space but reentered more strategically with acquisitions in cell and gene therapy manufacturing, aligning better with its biologics testing expertise. This focused approach positions Charles River as a critical and growing player in supporting biopharma through complex preclinical safety testing and manufacturing for cutting-edge therapies. For a comprehensive analysis of another standout stock in the healthcare industry, be sure to check out our article on Danaher Corporation (DHR), wherein we summarized a bullish thesis by Best Anchor Stocks on Substack. Charles River Laboratories International, Inc. (CRL) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 39 hedge fund portfolios held CRL at the end of the first quarter which was 45 in the previous quarter. While we acknowledge the risk and potential of CRL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CRL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
